期刊
GLYCOCONJUGATE JOURNAL
卷 30, 期 1, 页码 67-76出版社
SPRINGER
DOI: 10.1007/s10719-012-9445-7
关键词
Congenital disorders of glycosylation; Genetic testing; Disease identification; Homozygosity mapping; Autozygosity; Exome sequencing; Next generation sequencing; Time line
资金
- FWO (Fonds voor Wetenschappelijk Onderzoek, Vlaanderen, Belgium) [G.0553.08, G.0505.12]
- ERA-Net for Research Programmes on Rare Diseases Joint Transnational Call (EURO-CDG) [ERARE11-135]
- Great Ormond Street Hospital Childrens Charity [V1273] Funding Source: researchfish
In the past decade, the identification of most genes involved in Congenital Disorders of Glycosylation (CDG) (type I) was achieved by a combination of biochemical, cell biological and glycobiological investigations. This has been truly successful for CDG-I, because the candidate genes could be selected on the basis of the homology of the synthetic pathway of the dolichol linked oligosaccharide in human and yeast. On the contrary, only a few CDG-II defects were elucidated, be it that some of the discoveries represent wonderful breakthroughs, like e.g, the identification of the COG defects. In general, many rare genetic defects have been identified by positional cloning. However, only a few types of CDG have effectively been elucidated by linkage analysis and so-called reverse genetics. The reason is that the families were relatively small and could-except for CDG-PMM2-not be pooled for analysis. Hence, a large number of CDG cases has long remained unsolved because the search for the culprit gene was very laborious, due to the heterogeneous phenotype and the myriad of candidate defects. This has changed when homozygosity mapping came of age, because it could be applied to small (consanguineous) families. Many novel CDG genes have been discovered in this way. But the best has yet to come: what we are currently witnessing, is an explosion of novel CDG defects, thanks to exome sequencing: seven novel types were published over a period of only two years. It is expected that exome sequencing will soon become a diagnostic tool, that will continuously uncover new facets of this fascinating group of diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据